Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Biora Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 32 | 31 | −1 |
| Shares | 2.33M | 3.44M | +1.11M (+47.5%) |
| Value | $6.46M | $13.2M | +$6.79M (+105.1%) |
New holders (6)
Institutions that held Biora Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 617,126 | $2.38M | 0.71% |
| Sabby Management, LLC | 482,609 | $1.86M | 6.65% |
| UBS Group AG | 1,846 | $7.11K | 0.00% |
| Bank of America Corp | 1,239 | $4.77K | 0.00% |
| FMR LLC | 26 | $100 | 0.00% |
| Rhumbline Advisers | 17 | $67 | 0.00% |
Sold out (7)
Institutions that held Biora Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 16,400 | $45.4K |
| Virtu Financial LLC | 10,640 | $29.0K |
| JPMorgan Chase & Co | 2,243 | $6.00K |
| Citadel Advisors LLC | 1,387 | $3.84K |
| Royal Bank of Canada | 19 | $0 |
| Hantz Financial Services, Inc. | 3 | $0 |
| Cutler Group LP | 24 | $0 |